Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Treatment of inner ear hair cells

A technology of inner ear hair cells and supporting cells, which can be applied to or improve inner ear tissue, promotion, and induction, and can solve problems such as irreversible and permanent hearing damage

Inactive Publication Date: 2007-05-02
GENENTECH INC
View PDF33 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, with long-term and high-dose use of the drug, hearing damage can become permanent and irreversible, as has been clinically reported (Jarvis, 1966)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Treatment of inner ear hair cells
  • Treatment of inner ear hair cells
  • Treatment of inner ear hair cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0107] Research on the characteristics of hair cells

[0108] It was determined that cultured utricular epithelial cells were determined to exhibit characteristics of epithelial cells, but not fibroblasts, glial cells, or neuronal cells.

[0109] Using 0.5 mg / ml thermolysin (Sigma; in Hank's calcium-magnesium-free balanced salt solution) at 37°C for 30 min, according to a previously reported method (Corwin et al., 1995), from postpartum days 4-5 ( Utricle epithelial sheets were isolated from P4-5) Wistar rats. Epithelial sheets were then incubated at 37°C for 8 minutes in a mixture of 0.125% trypsin and 0.125% collagenase (Fig. 1A). Enzyme activity was inactivated with a mixture of 0.005% soybean trypsin inhibitor (Sigma) and 0.005% DNase (Worthington) and then pipetted up and down in 0.05% DNase BME solution 10 times with a 1 ml pipette tip. In this way, epithelial sheets were partially dissociated into small pieces containing approximately 10-80 cells (Fig. 1B). Since we ...

Embodiment II

[0129] Stimulates the regeneration of hair cells

[0130] In order to test whether the currently known growth factors can stimulate the proliferation of Utricle Sertoli cells, we used tritiated thymidine incorporation test to measure the DNA synthesis. To measure DNA synthesis, after 24 hours of incubation, add 3 H-thymidine (2 μCi / well) was used for 24 hours, and then the cells were harvested with a Tomtec cell harvester. Because epithelial cells were grown on a polylysine matrix, trypsin (1 mg / ml) was added to the culture wells for 25 minutes at 37°C to detach the cells and then harvested. Counts (Cpm / well) were performed using a Matrix 9600 gas phase counter (Packard Instrument Company, IL) as previously described (Gao et al., 1995). The data of 5-10 wells for each test group were collected and presented in the form of mean ± mean square error (s.e.m.). Statistical analysis was performed using a two-tailed, unpaired t-test. Under control culture conditions, moderate lev...

Embodiment III

[0146] Comparison of Mitogens

[0147]To compare the potency of FGF-2 with IGF-1 and TGF-α, a dose-dependent study was performed in utricular epithelial cell cultures in the range of 0.1-100 ng / ml (Figure 4). At a concentration of 0.1 ng / ml, none of the three growth zones showed a detectable effect (p > 0.05). At a concentration of 1 ng / ml, FGF-2 exhibited a significant mitogenic effect (p<0.01) whereas IGF-1 and TGF-α had no detectable effect. At higher doses (10-100 ng / ml), all three growth factors showed significant mitogenic effects (p<0.05) compared to control cultures. However, FGF-2 was more effective than IGF-1 or TGF-α (p<0.01; Figure 4). Higher potency of FGF-2 than IGF-1 or TGF-α was also observed by BrdU immunocytochemical analysis (Table 2).

[0148] To determine whether FGF-2 acts synergistically with IGFF-1 or TGF-α, FGF-2 was added to the cultures together with IGF-1, or with TGF-α. Both tritiated thymidine incorporation and BrdU immunocytochemical analysis...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Compositions, methods, and devices are provided for inducing or enhancing the growth, proliferation, regeneration of inner ear tissue, particularly inner ear hair cells. In addition, provided are compositions and methods for prophylactic or therapeutic treatment of a mammal afflicted with an inner ear disorder or condition, particularly for hearing impairments involving hair cell damage, loss, or degeneration, by administration of a therapeutically effective amount of IGF-1 or FGF-2, or their agonists, alone or in combination.

Description

technical field [0001] The application of the present invention relates to inducing, promoting, or improving inner ear tissue, especially the growth, proliferation or regeneration of inner ear epidermal hair cells. Furthermore, the present invention provides methods, compositions and devices for the prevention and treatment of diseases and disorders of the inner ear, especially hearing impairment. The method comprises administering insulin-like growth factor-I (IGF-I) and / or fibroblast growth factor-2 (FGF-2), or an agonist thereof. Background technique [0002] Hearing impairment is a serious disability that affects millions of people. Hearing damage can be caused by a variety of different causes, including infection, physical injury, loud sounds, aging, and chemical-induced ototoxicity (which destroys neurons and / or hair cells in the peripheral auditory system) . The peripheral auditory system consists of auditory receptors, the hair cells in the organ of Corti, and pri...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/18A61K38/30A61P27/16A61K45/00A61KA61K38/27A61P43/00C07KC12N
CPCA61K38/30A61K38/1825A61K38/1841A61P27/16A61P43/00A61K2300/00
Inventor 高维强
Owner GENENTECH INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com